Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2022-02-09
09:22 am
Purchase
13GNabriva Therapeutics plc
NBRV
FMR LLC2,215,958
3.847%
786,699increase
(+55.04%)
View
2021-11-19
12:57 pm
Purchase
13GNabriva Therapeutics plc
NBRV
Lincoln Park Capital Fund LLC4,512,589
7.96%
4,512,589increase
(New Position)
View
2021-02-08
10:35 am
Purchase
13GNabriva Therapeutics plc
NBRV
FMR LLC1,429,259
6.78%
1,429,259increase
(New Position)
View
2020-02-12
4:32 pm
Purchase
13GNabriva Therapeutics plc
NBRV
Longitude Capital Partners II LLC4,256,527
4.5%
244,152increase
(+6.08%)
View
2020-02-07
11:26 am
Purchase
13GNabriva Therapeutics plc
NBRV
FMR LLC6,131,900
6.485%
6,131,900increase
(New Position)
View
2019-12-26
4:01 pm
Unchanged
13DNabriva Therapeutics plc
NBRV
ORBIMED ADVISORS LLC4,644,600
4.9%
0
(Unchanged)
View
2019-12-06
4:46 pm
Unchanged
13DNabriva Therapeutics plc
NBRV
ORBIMED ADVISORS LLC4,644,600
5.9%
0
(Unchanged)
View
2019-08-14
4:31 pm
Sale
13GNabriva Therapeutics plc
NBRV
Vivo Capital VIII LLC3,528,566
4.8%
-1,272,767decrease
(-26.51%)
View
2019-07-01
4:52 pm
Sale
13GNabriva Therapeutics plc
NBRV
Novo Holdings A/S3,446,564
4.74%
-1,257,156decrease
(-26.73%)
View
2019-02-14
4:48 pm
Sale
13GNabriva Therapeutics plc
NBRV
HBM Healthcare Investments (Cayman) Ltd.1,834,007
11%
-500,001decrease
(-21.42%)
View
2019-02-14
3:25 pm
Unchanged
13GNabriva Therapeutics plc
NBRV
Vivo Capital VIII LLC4,801,333
7.2%
0
(Unchanged)
View
2019-02-14
3:08 pm
Purchase
13GNabriva Therapeutics plc
NBRV
Frazier Healthcare VII L.P.4,256,526
6.4%
244,152increase
(+6.08%)
View
2019-02-14
08:49 am
Sale
13GNabriva Therapeutics plc
NBRV
venBio Global Strategic Fund II L.P.0
0%
-2,122,962decrease
(Position Closed)
View
2019-02-11
11:55 am
Sale
13GNabriva Therapeutics plc
NBRV
WELLINGTON MANAGEMENT GROUP LLP0
0%
-3,594,568decrease
(Position Closed)
View
2019-02-08
09:21 am
Sale
13GNabriva Therapeutics plc
NBRV
WELLINGTON MANAGEMENT GROUP LLP3,594,568
5.37%
-1,437,108decrease
(-28.56%)
View
2019-02-01
11:45 am
Purchase
13GNabriva Therapeutics plc
NBRV
Novo Holdings A/S4,703,720
7.02%
1,778,898increase
(+60.82%)
View
2018-08-10
09:41 am
Sale
13GNabriva Therapeutics plc
NBRV
WELLINGTON MANAGEMENT GROUP LLP5,031,676
7.57%
-108,613decrease
(-2.11%)
View
2018-08-07
4:51 pm
Purchase
13GNabriva Therapeutics plc
NBRV
Longitude Capital Partners II LLC4,012,375
6%
4,012,375increase
(New Position)
View
2018-08-06
4:32 pm
Purchase
13GNabriva Therapeutics plc
NBRV
Vivo Capital VIII LLC4,801,333
7.2%
727,143increase
(+17.85%)
View
2018-08-02
8:20 pm
Purchase
13GNabriva Therapeutics plc
NBRV
Frazier Healthcare VII L.P.4,012,374
6%
4,012,374increase
(New Position)
View
Goto 0, 1, Next